Stay fully informed. Get the latest news from Brooklyn ImmunoTherapeutics.

December 2, 2021

Brooklyn ImmunoTherapeutics to Present at Two Upcoming December Conferences

November 29, 2021

Brooklyn ImmunoTherapeutics Welcomes Susan McClatchey as Vice President and Head of Quality

October 14, 2021

Brooklyn ImmunoTherapeutics to Move Stock Exchange Listing to Nasdaq

September 22, 2021

Brooklyn ImmunoTherapeutics Appoints Roger Sidhu, M.D. as Chief Medical Officer

September 21, 2021

Brooklyn ImmunoTherapeutics Provides Highlights of Shareholder Update Call from September 20, 2021

September 13, 2021

Brooklyn ImmunoTherapeutics to Conduct Shareholder Update Conference Call on Monday, September 20, 2021, at 4:30 PM ET

September 9, 2021

Brooklyn ImmunoTherapeutics to Participate in Grand Opening of Cambridge-Based mRNA Cleanroom Facility Shared with Factor Bioscience

August 20, 2021

Brooklyn ImmunoTherapeutics Provides Highlights of Shareholder Update Call from August 19, 2021

August 20, 2021

Brooklyn ImmunoTherapeutics Announces Adjournment of Annual Meeting of Stockholders Due to Lack of Quorum

August 16, 2021

Brooklyn ImmunoTherapeutics to Conduct Shareholder Update Conference Call on Thursday, August 19, 2021 at 4:30 PM ET